A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam
Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized
(Non-Metastatic) Rectal Cancer
Observational
Observational Model: Case Control, Time Perspective: Cross-Sectional
Shouki Bazarbashi, M.D.
Principal Investigator
KFSH & RC
United States: Institutional Review Board
RAC# 2071-051
NCT01310985
March 2008
Name | Location |
---|